CMV central nervous system disease in stem-cell transplant recipients: an increasing complication of drug-resistant CMV infection and protracted immunodeficiency

75: Prevention of Late CMV Disease After HCT: A Randomized Double-Blind Multicenter Trial of Valganciclovir (VGCV) Prophylaxis Versus PCR-guided GCV/VGCV Preemptive Therapy

(2008) M. Boeckh et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study

(2008) D. J. Winston et al.   BLOOD

Cytotoxic T lymphocytes as immune-therapy in haematological practice

(2008) Ann M. Leen et al.   BRITISH JOURNAL OF HAEMATOLOGY

Umbilical cord blood transplantation: Basic biology and clinical challenges to immune reconstitution

(2008) Julia A. Brown et al.   CLINICAL IMMUNOLOGY

A Cytomegalovirus Vaccine for Transplantation: Are We Closer?

(2008) Vera Go et al.   JOURNAL OF INFECTIOUS DISEASES

Safety and Immunogenicity of a Bivalent Cytomegalovirus DNA Vaccine in Healthy Adult Subjects

(2008) Mary K. Wloch et al.   JOURNAL OF INFECTIOUS DISEASES

Cytomegalovirus encephalitis/retinitis in allogeneic haematopoietic stem cell transplant recipient treated successfully with combination of cidofovir and foscarnet

(2008) Petr Hubacek et al.   PEDIATRIC TRANSPLANTATION